• Explore /
  • Poster
  • / Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).

Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).

Abstract Poster

Authors

null

Julie M. Shabto

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Julie M. Shabto , Dylan J Martini , Yuan Liu , Deepak Ravindranathan , Meredith R Kline , Elise Hitron , Greta Russler , Sarah Caulfield , Haydn Kissick , Mehrdad Alemozaffar , Kenneth Ogan , Wayne Harris , Viraj A. Master , Bradley Curtis Carthon , Omer Kucuk , Mehmet Asim Bilen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 472)

DOI

10.1200/JCO.2019.37.7_suppl.472

Abstract #

472

Poster Bd #

K21

Abstract Disclosures

Similar Posters

First Author: Julie M. Shabto

First Author: Julie M. Shabto

First Author: Juan José Soto

First Author: Glenn J. Hanna